• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄调整后的全球肾小球硬化症在 IgA 肾病患者中更能准确预测肾脏进展。

Age-adjusted global glomerulosclerosis predicts renal progression more accurately in patients with IgA nephropathy.

机构信息

Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.

Department of Pathology, College of Medicine, Soonchunhyang University, Cheonan, Korea.

出版信息

Sci Rep. 2020 Apr 14;10(1):6270. doi: 10.1038/s41598-020-63366-0.

DOI:10.1038/s41598-020-63366-0
PMID:32286437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7156438/
Abstract

The Oxford classification was developed to predict the outcome of IgA nephropathy (IgAN). Based on the upper reference limit (95 percentile) for the number of globally sclerotic glomeruli (GSG) expected on biopsy according to age, we evaluated whether the prognosis of IgAN was affected by the age-calibrated numbers of GSG independent of the Oxford classification. Patients diagnosed with IgAN on renal biopsy in a single center from January 2011 to December 2018 were analyzed retrospectively. Patients with more GSG number than the upper reference limit expected on biopsy according to age were categorized in a group of GSG abnormal for age. We analyzed in two ways, calculating the median rate of decline in estimated glomerular filtration rate (eGFR) and time-to-event defined as a decline of eGFR level to 40% lower than the baseline. There were 111 patients in the group of GSG abnormal for age. In this group, the rate of eGFR decline was faster by 1.85 (3.68-0.03) ml/min/1.73 m per year in the fully-adjusted robust regression model. The adjusted hazard ratio for eGFR decline for renal outcome was 29.10 (2.18-388.49). The cumulative incidence of CKD progression was significantly higher, especially for those with T score of 0 in the Oxford classification. We suggest that GSG abnormal for age is an independent risk factor in predicting the renal outcome of IgAN.

摘要

牛津分类法是为了预测 IgA 肾病 (IgAN) 的结果而开发的。基于根据年龄预测活检时肾小球全球硬化数 (GSG) 的上界(95 百分位),我们评估了 IgAN 的预后是否受到年龄校准的 GSG 数量的影响,而不考虑牛津分类法。对 2011 年 1 月至 2018 年 12 月在一家单中心进行肾活检诊断为 IgAN 的患者进行回顾性分析。根据年龄预测活检时肾小球全球硬化数高于上界的患者被归类为 GSG 年龄异常组。我们用两种方法进行分析,计算估计肾小球滤过率 (eGFR) 下降的中位数率和事件时间定义为 eGFR 水平下降至基线以下 40%的时间。GSG 年龄异常组有 111 例患者。在该组中,在完全调整后的稳健回归模型中,eGFR 下降的速度更快,为 1.85(3.68-0.03)ml/min/1.73 m/年。调整后的 eGFR 下降对肾脏结局的风险比为 29.10(2.18-388.49)。CKD 进展的累积发生率明显更高,尤其是在牛津分类法中 T 评分为 0 的患者中。我们建议 GSG 年龄异常是预测 IgAN 肾脏结局的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a635/7156438/078e55078d6a/41598_2020_63366_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a635/7156438/67143bfdec51/41598_2020_63366_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a635/7156438/717cc79d13b2/41598_2020_63366_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a635/7156438/078e55078d6a/41598_2020_63366_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a635/7156438/67143bfdec51/41598_2020_63366_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a635/7156438/717cc79d13b2/41598_2020_63366_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a635/7156438/078e55078d6a/41598_2020_63366_Fig3_HTML.jpg

相似文献

1
Age-adjusted global glomerulosclerosis predicts renal progression more accurately in patients with IgA nephropathy.年龄调整后的全球肾小球硬化症在 IgA 肾病患者中更能准确预测肾脏进展。
Sci Rep. 2020 Apr 14;10(1):6270. doi: 10.1038/s41598-020-63366-0.
2
Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.新月体数量影响无明显慢性肾脏病理的 IgA 肾病患者的预后。
Am J Nephrol. 2021;52(6):507-518. doi: 10.1159/000516187. Epub 2021 Jun 16.
3
Total Nephron Number and Single-Nephron Parameters in Patients with IgA Nephropathy.IgA 肾病患者的总肾单位数和单肾单位参数。
Kidney360. 2021 Mar 10;2(5):828-841. doi: 10.34067/KID.0006972020. eCollection 2021 May 27.
4
The role of hypertriglyceridemia and treatment patterns in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis.高比例全球肾小球硬化的 IgA 肾病中高甘油三酯血症的作用和治疗模式。
Int Urol Nephrol. 2020 Feb;52(2):325-335. doi: 10.1007/s11255-019-02371-3. Epub 2020 Jan 18.
5
Extracapillary proliferation is an independent predictive factor in Immunoglobulin A nephropathy.毛细血管外增生是IgA肾病的一个独立预测因素。
Nephrology (Carlton). 2015 Sep;20(9):654-9. doi: 10.1111/nep.12497.
6
IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.基于牛津分类法的IgA肾病临床病理研究:进展特点及性别差异
Medicina (Kaunas). 2016;52(6):340-348. doi: 10.1016/j.medici.2016.11.003. Epub 2016 Nov 22.
7
Clinical outcomes of IgA nephropathy patients with different proportions of crescents.不同新月体比例的IgA肾病患者的临床结局
Medicine (Baltimore). 2017 Mar;96(11):e6190. doi: 10.1097/MD.0000000000006190.
8
Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.可溶性白细胞介素-2 受体α预测 IgA 肾病的肾脏结局。
Nephrol Dial Transplant. 2012 May;27(5):1916-23. doi: 10.1093/ndt/gfr554. Epub 2011 Sep 22.
9
Glomerular tip adhesions predict the progression of IgA nephropathy.肾小球尖端黏附预测 IgA 肾病的进展。
BMC Nephrol. 2013 Dec 5;14:272. doi: 10.1186/1471-2369-14-272.
10
Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.预测轻度蛋白尿型IgA肾病进展的临床病理特征
Kidney Blood Press Res. 2018;43(2):318-328. doi: 10.1159/000487901. Epub 2018 Mar 6.

引用本文的文献

1
Global glomerulosclerosis proportions predict nephropathy progression in IgA nephropathy: a multicenter retrospective analysis with propensity score matching.全球肾小球硬化比例可预测IgA肾病的肾病进展:一项倾向评分匹配的多中心回顾性分析
Ren Fail. 2025 Dec;47(1):2486567. doi: 10.1080/0886022X.2025.2486567. Epub 2025 May 5.
2
Clinicopathological Characteristics of Adult IgA Nephropathy in the United States.美国成人IgA肾病的临床病理特征
Kidney Int Rep. 2023 Jun 28;8(9):1792-1800. doi: 10.1016/j.ekir.2023.06.016. eCollection 2023 Sep.
3
Holistic fine-grained global glomerulosclerosis characterization: from detection to unbalanced classification.

本文引用的文献

1
The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.原发性肾脏活检组织学病变的预后价值:来自波士顿肾脏活检队列研究的结果。
J Am Soc Nephrol. 2018 Aug;29(8):2213-2224. doi: 10.1681/ASN.2017121260. Epub 2018 Jun 4.
2
Age-adjusted global glomerulosclerosis in addition to Oxford histological classification of IgA nephropathy.除IgA肾病的牛津组织学分类外,年龄校正后的全球肾小球硬化症。
Kidney Int. 2018 May;93(5):1250. doi: 10.1016/j.kint.2018.02.010.
3
Soluble klotho as a marker of renal fibrosis and podocyte injuries in human kidneys.
整体细粒度全局肾小球硬化特征分析:从检测到不平衡分类
J Med Imaging (Bellingham). 2022 Jan;9(1):014005. doi: 10.1117/1.JMI.9.1.014005. Epub 2022 Feb 17.
4
Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy.高血压性肾硬化症在高血压动物模型中的比较分析及其与人类病理学的相关性。肾小球病变。
PLoS One. 2022 Feb 17;17(2):e0264136. doi: 10.1371/journal.pone.0264136. eCollection 2022.
可溶性 klotho 作为人类肾脏纤维化和足细胞损伤的标志物。
PLoS One. 2018 Mar 28;13(3):e0194617. doi: 10.1371/journal.pone.0194617. eCollection 2018.
4
An update on predicting renal progression in IgA nephropathy.IgA 肾病中预测肾功能进展的研究进展。
Curr Opin Nephrol Hypertens. 2018 May;27(3):214-220. doi: 10.1097/MNH.0000000000000405.
5
Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.全球肾小球硬化伴肾病综合征;年龄调整的临床重要性。
Kidney Int. 2018 May;93(5):1175-1182. doi: 10.1016/j.kint.2017.09.028. Epub 2017 Dec 19.
6
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.口服甲泼尼龙对IgA肾病患者临床结局的影响:TESTING随机临床试验
JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362.
7
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.牛津 IgA 肾病分类 2016 年更新:IgA 肾病分类工作组的报告。
Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22.
8
A proposal for standardized grading of chronic changes in native kidney biopsy specimens.关于对原发性肾脏活检标本中慢性改变进行标准化分级的建议。
Kidney Int. 2017 Apr;91(4):787-789. doi: 10.1016/j.kint.2017.01.002.
9
Diagnosis and treatment of patients with IgA nephropathy in Japan.日本IgA肾病患者的诊断与治疗
Kidney Res Clin Pract. 2016 Dec;35(4):197-203. doi: 10.1016/j.krcp.2016.09.001. Epub 2016 Sep 15.
10
The global burden of chronic kidney disease: estimates, variability and pitfalls.全球慢性肾脏病负担:估计值、变异性和陷阱。
Nat Rev Nephrol. 2017 Feb;13(2):104-114. doi: 10.1038/nrneph.2016.163. Epub 2016 Dec 12.